1. Home
  2. LMND vs IMVT Comparison

LMND vs IMVT Comparison

Compare LMND & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$80.74

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$26.38

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
IMVT
Founded
2015
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LMND
IMVT
Price
$80.74
$26.38
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$56.25
$28.38
AVG Volume (30 Days)
2.3M
2.1M
Earning Date
02-24-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$658,300,000.00
N/A
Revenue This Year
$40.13
N/A
Revenue Next Year
$59.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
33.66
N/A
52 Week Low
$24.31
$12.72
52 Week High
$85.20
$27.69

Technical Indicators

Market Signals
Indicator
LMND
IMVT
Relative Strength Index (RSI) 57.48 56.91
Support Level $69.69 $24.70
Resistance Level $84.84 $27.38
Average True Range (ATR) 3.96 1.04
MACD -0.02 -0.13
Stochastic Oscillator 72.57 54.76

Price Performance

Historical Comparison
LMND
IMVT

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: